SCHEMBL23944204

SCHEMBL23944204

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cncc5oc6cc7ccccc7cc6c45)c4ccccc34)n2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCZ Q05513 1/20 0.33
SMN1; SMN2 Q16637 5/20 0.32
MAPT P10636 5/20 0.32
KDM4E B2RXH2 4/20 0.32
ALDH1A1 P00352 4/20 0.32
HSD17B10 Q99714 3/20 0.32
HPGD P15428 3/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
TP53 P04637 2/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 2/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ATM Q13315 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP1A2 P05177 4/20 0.32
CYP11B1 P15538 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24763440 0.98 PRKCZ (0.35) PRKCZSMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL24763457 0.96 MAPT (0.36) PRKCZSMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL23944209 0.95 ALDH1A1 (0.40) PRKCZSMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL24762132 0.95 CYP1A2 (0.38) PRKCZSMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL24762823 0.95 PRKCZ (0.33) PRKCZSMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL23944212 0.95 MAP3K8 (0.32) PRKCZSMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL23944804 0.94 PRKCZ (0.35) PRKCZSMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL24762858 0.93 MAPT (0.33) SMN1; SMN2MAPTKDM4EALDH1A1HSD17B10
SCHEMBL24762913 0.92 SMN1; SMN2 (0.34) PRKCZSMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL24762997 0.92 ALDH1A1 (0.37) PRKCZSMN1; SMN2MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220402928-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2022-12-22 US disclosed
WO-2021210910-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402928-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, CRY1, CRY2 PRKCZ 4773/4885SMN1; SMN2 2675/4885MAPT 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.